Patents by Inventor Robert B. Nussenblatt

Robert B. Nussenblatt has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • OCULAR THERAPEUTIC AGENT DELIVERY DEVICES AND METHODS FOR MAKING AND USING SUCH DEVICES
    Publication number: 20160158146
    Abstract: Ocular implant devices (10, 20, 121) for the delivery of a therapeutic agent to an eye (101, 301) in a controlled and sustained manner. Dual mode and single mode drug delivery devices (10, 20, 121) are illustrated and described. Implants (10, 20) suitable for subconjunctival placement are described. Implants (121, 10, 20) suitable for intravitreal placement also are described. The invention also includes fabrication and implementation techniques associated with the unique ocular implant devices (10, 20, 121) that are presented herein.
    Type: Application
    Filed: February 17, 2016
    Publication date: June 9, 2016
    Inventors: Michael R. Robinson, Karl G. Csaky, Robert B. Nussenblatt, Janine A. Smith, Peng Yuan, Cynthia Sung, Matthew P. Fronheiser, Hyuncheol Kim
  • OCULAR THERAPEUTIC AGENT DELIVERY DEVICES AND METHDOS FOR MAKING AND USING SUCH DEVICES
    Publication number: 20100272777
    Abstract: Ocular implant devices (10, 20, 121) for the delivery of a therapeutic agent to an eye (101, 301) in a controlled and sustained manner. Dual mode and single mode drug delivery devices (10, 20, 121) are illustrated and described. Implants (10, 20) suitable for subconjunctival placement are described. Implants (121, 10, 20) suitable for intravitreal placement also are described. The invention also includes fabrication and implementation techniques associated with the unique ocular implant devices (10, 20, 121) that are presented herein.
    Type: Application
    Filed: December 28, 2009
    Publication date: October 28, 2010
    Applicants: Department of Health
    Inventors: Michael R. Robinson, Karl G. Csaky, Robert B. Nussenblatt, Janine A. Smith, Peng Yuan, Cynthia Sung, Matthew P. Fronheiser, Hyuncheol Kim
  • Ocular therapeutic agent delivery devices and methods for making and using such devices
    Patent number: 7658364
    Abstract: Ocular implant devices (10, 20, 121) for the delivery of a therapeutic agent to an eye (101, 301) in a controlled and sustained manner. Dual mode and single mode drug delivery devices (10, 20, 121) are illustrated and described. Implants (10, 20) suitable for subconjunctival placement are described. Implants (121, 10, 20) suitable for intravitreal placement also are described. The invention also includes fabrication and implementation techniques associated with the unique ocular implant devices (10, 20, 121) that are presented herein.
    Type: Grant
    Filed: March 14, 2002
    Date of Patent: February 9, 2010
    Assignee: The United States of America as represented by the Department of Health and Human Services
    Inventors: Michael R. Robinson, Karl G. Csaky, Robert B. Nussenblatt, Janine A. Smith, Peng Yuan, Cynthia Sung, Matthew P. Fronheiser, Hyuncheol Kim
  • Ocular therapeutic agent delivery devices and methods for making and using such devices
    Publication number: 20040180075
    Abstract: Ocular implant devices (10, 20, 121) for the delivery of a therapeutic agent to an eye (101, 301) in a controlled and sustained manner. Dual mode and single mode drug delivery devices (10, 20, 121) are illustrated and described. Implants (10, 20) suitable for subconjunctival placement are described. Implants (121, 10, 20) suitable for intravitreal placement also are described. The invention also includes fabrication and implementation techniques associated with the unique ocular implant devices (10, 20, 121) that are presented herein.
    Type: Application
    Filed: May 3, 2004
    Publication date: September 16, 2004
    Inventors: Michael R. Robinson, Karl G. Csaky, Robert B. Nussenblatt, Janine A Smith, Peng Yuan, Cynthia Sung, Matthew P. Fronheiser, Hyuncheol Kim
  • Ocular therapeutic agent delivery devices and methods for making and using such devices
    Patent number: 6713081
    Abstract: Ocular implant devices for the delivery of a therapeutic agent to an eye in a controlled and sustained manner. Dual mode and single mode drug delivery devices are illustrated and described. Implants suitable for subconjunctival placement are described. Implants suitable for intravitreal placement also are described. The invention also includes fabrication and implementation techniques associated with the unique ocular implant devices that are presented herein.
    Type: Grant
    Filed: March 15, 2001
    Date of Patent: March 30, 2004
    Assignee: The United States of America as represented by the Department of Health and Human Services
    Inventors: Michael R. Robinson, Karl G. Csaky, Peng Yuan, Cynthia Sung, Robert B. Nussenblatt, Janine A. Smith
  • Ocular therapeutic agent delivery devices and methods for making and using such devices
    Publication number: 20030175324
    Abstract: Ocular implant devices for the delivery of a therapeutic agent to an eye in a controlled and sustained manner. Dual mode and single mode drug delivery devices are illustrated and described. Implants suitable for subconjunctival placement are described. Implants suitable for intravitreal placement also are described. The invention also includes fabrication and implementation techniques associated with the unique ocular implant devices that are presented herein.
    Type: Application
    Filed: March 15, 2001
    Publication date: September 18, 2003
    Inventors: Michael R. Robinson, Karl G. Csaky, Peng Yuan, Cynthia Sung, Robert B. Nussenblatt, Janine A. Smith
  • Method of treating or preventing autoimmune uveoretinitis in mammals
    Patent number: 5961977
    Abstract: The present invention provides a method of treating or preventing the clinical manifestation of an autoimmune disease having the symptoms of uveoretinitis in a mammal in need of such treatment comprising orally administering to said mammal an effective amount of an autoantigen, e.g., S antigen (S-Ag), and/or biologically active fragments, or analogs thereof specific for uveoretinitis.Also provided is a pharmaceutical formulation useful for treating or preventing uveoretinitis in mammals comprising an effective amount of one or more of the foregoing autoantigen, fragments or analogs.
    Type: Grant
    Filed: April 10, 1995
    Date of Patent: October 5, 1999
    Assignees: AutoImmune Inc., The United States of America as represented by the Department of Health and Human Services
    Inventors: David Allen Hafler, Robert B. Nussenblatt, Alan G. Palestine, Howard L. Weiner
  • Blocking cell adhesion molecules and treating animals with ocular inflammation
    Patent number: 5597567
    Abstract: The present invention relates, in general, to a method of blocking of cell adhesion molecules. In particular, the present invention relates to a method of blocking cell adhesion molecules with monoclonal antibodies or synthesized substances.
    Type: Grant
    Filed: February 4, 1994
    Date of Patent: January 28, 1997
    Assignee: The United States of America as represented by the Department of Health and Human Services
    Inventors: Scott M. Whitcup, Chi-Chao Chan, Robert B. Nussenblatt
  • Method of treating ocular diseases by periocular administration of cyclosporine A or G
    Patent number: 5294604
    Abstract: The present invention provides a method of treating ocular diseases by the administration of cyclosporine A or G by periocular injection in a pharmaceutically acceptable carrier.
    Type: Grant
    Filed: December 20, 1989
    Date of Patent: March 15, 1994
    Assignee: The Government of the United States of America as represented by the Secretary of the Department of Health and Human Services
    Inventors: Robert B. Nussenblatt, Alan G. Palestine